Ubs Group Ag Horizon Therapeutics Public LTD CO Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023
SELL
$98.98 - $115.74 $5.48 Million - $6.41 Million
-55,366 Reduced 9.39%
534,044 $61.8 Million
Q2 2023

Aug 11, 2023
BUY
$96.34 - $112.38 $31 Million - $36.1 Million
321,292 Added 119.83%
589,410 $60.6 Million
Q1 2023

May 12, 2023
SELL
$107.32 - $113.5 $16.5 Million - $17.5 Million
-153,818 Reduced 36.46%
268,118 $29.3 Million
Q4 2022

Feb 08, 2023
SELL
$62.39 - $113.8 $9.56 Million - $17.4 Million
-153,201 Reduced 26.64%
421,936 $48 Million
Q3 2022

Nov 10, 2022
BUY
$58.92 - $84.67 $6.02 Million - $8.65 Million
102,103 Added 21.58%
575,137 $35.6 Million
Q2 2022

Aug 10, 2022
SELL
$79.4 - $116.36 $3.38 Million - $4.96 Million
-42,618 Reduced 8.26%
473,034 $37.7 Million
Q1 2022

May 16, 2022
SELL
$86.42 - $109.81 $10.4 Million - $13.2 Million
-119,896 Reduced 18.86%
515,652 $54.3 Million
Q4 2021

Feb 14, 2022
BUY
$98.56 - $119.91 $6.66 Million - $8.1 Million
67,579 Added 11.9%
635,548 $68.5 Million
Q3 2021

Nov 15, 2021
BUY
$91.91 - $110.37 $18.1 Million - $21.8 Million
197,099 Added 53.15%
567,969 $62.2 Million
Q2 2021

Aug 13, 2021
SELL
$86.24 - $95.92 $5.25 Million - $5.84 Million
-60,852 Reduced 14.1%
370,870 $34.7 Million
Q1 2021

May 12, 2021
SELL
$71.83 - $95.48 $27.6 Million - $36.7 Million
-384,035 Reduced 47.08%
431,722 $39.7 Million
Q4 2020

Feb 11, 2021
BUY
$67.0 - $84.39 $36.2 Million - $45.6 Million
540,465 Added 196.32%
815,757 $59.7 Million
Q3 2020

Nov 12, 2020
BUY
$55.23 - $79.93 $7.8 Million - $11.3 Million
141,208 Added 105.31%
275,292 $21.4 Million
Q2 2020

Jul 31, 2020
SELL
$30.2 - $56.98 $5.05 Million - $9.52 Million
-167,144 Reduced 55.49%
134,084 $7.45 Million
Q1 2020

May 01, 2020
BUY
$24.87 - $38.56 $2.18 Million - $3.38 Million
87,726 Added 41.09%
301,228 $8.92 Million
Q4 2019

Feb 14, 2020
BUY
$25.43 - $36.67 $253,791 - $365,966
9,980 Added 4.9%
213,502 $7.73 Million
Q3 2019

Nov 14, 2019
SELL
$23.0 - $27.97 $564,190 - $686,104
-24,530 Reduced 10.76%
203,522 $5.54 Million
Q2 2019

Aug 14, 2019
BUY
$22.81 - $28.48 $5.2 Million - $6.49 Million
228,052 New
228,052 $5.49 Million

Others Institutions Holding HZNP

# of Institutions
38
Shares Held
2.07M
Call Options Held
0
Put Options Held
20K
View Full List

About Horizon Therapeutics Public Ltd Co

HZNP Quotes by TradingView
  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email